CBD gel tested for Long-Term safety in fragile x kids and young adults
Disease control
Ongoing
This study looks at the long-term safety of a CBD gel (ZYN002) applied to the skin for children, teens, and young adults with Fragile X syndrome. Participants from two earlier studies will use the gel twice daily for 52 weeks. The main goal is to check for side effects, with a se…
Phase: PHASE2, PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC